A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

NCT03007888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Parkinson's Disease

Interventions

DRUG: Sinemet
DRUG: IPX203

Sponsor

Impax Laboratories, LLC